PEAK6 Investments’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

PEAK6 Investments’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-200	Closed	-$11K	–	5358
2021 Q3	$11K	Hold	200	–	–	﹤0.01%	4854
2021 Q2	$14K	Hold	200	–	–	﹤0.01%	4778
2021 Q1	$15K	Buy	+200	New	+$18.4K	﹤0.01%	4642
2020 Q1	–	Sell	-6,100	Closed	-$1.26M	–	4204
2019 Q4	$1.26M	Buy	6,100 +1,100	+22%	+$203K	0.01%	1396
2019 Q3	$763K	Buy	+5,000	New	+$819K	﹤0.01%	1961

Other funds holding LKFT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

PEAK6 Investments's LKFT Position: Q4 2019 in Review

PEAK6 Investments sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2019, closing a stake of 2,443 shares — an estimated $452K sold.

PEAK6 Investments first reported a position in LKFT in Q3 2019 and held it in 1 quarter. The position peaked at $373K in Q3 2019. 137 funds tracked by Wall St. Rank hold LKFT as of Q4 2019.

PEAK6 Investments reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2019 after selling out during the quarter.
PEAK6 Investments sold 2,443 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2019, an estimated $452K.
PEAK6 Investments first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2019 and held it in 1 quarter.
PEAK6 Investments's Lakefront Biotherapeutics American Depositary Shares position peaked at $373K in Q3 2019.
137 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2019.

Based on PEAK6 Investments's 13F filing for Q4 2019, filed 13 Feb 2020.